TABLE 4.
Total Cost-of-Care Savings (2021-2022)
| Diabetes | Savings based on Prime Therapeutics model10 ($) | Inflation-adjusted savingsa ($) |
|---|---|---|
| Total savings per patient difference: test | 61.88 | 72.21 |
| Total savings per patient difference: control | (31.19) | (36.40) |
| Savings per patient (difference) | 93.07 | 108.61 |
| Hypertension | ||
| Total savings per patient difference: test | 75.83 | 88.49 |
| Total savings per patient difference: control | (28.78) | (33.59) |
| Savings per patient (difference) | 104.61 | 122.08 |
| Cholesterol | ||
| Total savings per patient difference: test | 48.74 | 56.88 |
| Total savings per patient difference: control | (15.10) | (17.62) |
| Savings per patient (difference) | 63.84 | 74.50 |
a Prime Therapeutics model savings estimates, adjusted for inflation by $1.167.